Kronenwett; Ralf

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kronenwett; Ralf.The latest application filed is for "method for predicting the response to chemotherapy in a patient suffering from or at risk of developing recurrent breast cancer".

Company Profile

7.5.18

Kronenwett; Ralf - Cologne DE
KRONENWETT; Ralf - Colgone DE
KRONENWETT; Ralf - Salt Lake City UT
Kronenwett; Ralf - Koln DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Predicting The Response To Chemotherapy In A Patient Suffering From Or At Risk Of Developing Recurrent Breast Cancer App 20220307090 - Gehrmann; Mathias ; et al.	2022-09-29
Method For Breast Cancer Recurrence Prediction Under Endocrine Treatment App 20210123107 - DARTMANN; Mareike ; et al.	2021-04-29
Method for breast cancer recurrence prediction under endocrine treatment Grant 10,851,427 - Dartmann , et al. December 1, 2	2020-12-01
Method Of Using Biomarkers And Clinical Variables For Predicting Chemotherapy Benefit App 20200283855 - GUTIN; Alexander ; et al.	2020-09-10
Method For Breast Cancer Recurrence Prediction Under Endocrine Treatment App 20200224281 - DARTMANN; Mareike ; et al.	2020-07-16
Method for breast cancer recurrence prediction under endocrine treatment Grant 10,577,661 - Dartmann , et al.	2020-03-03
Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer Grant 10,301,685 - Brase , et al.	2019-05-28
Method For Predicting The Response To Chemotherapy In A Patient Suffering From Or At Risk Of Developing Recurrent Breast Cancer App 20190144949 - Gehrmann; Mathias ; et al.	2019-05-16
Method For Predicting Therapy Responsiveness In Basal Like Tumors App 20180251854 - Wirtz; Ralph Markus ; et al.	2018-09-06
Method For Predicting The Benefit From Inclusion Of Taxane In A Chemotherapy Regimen In Patients With Breast Cancer App 20180135133 - Brase; Jan ; et al.	2018-05-17
Method for predicting therapy responsiveness in basal like tumors Grant 9,932,639 - Wirtz , et al. April 3, 2	2018-04-03
Method For Predicting The Response To Chemotherapy In A Patient Suffering From Or At Risk Of Developing Recurrent Breast Cancer App 20170081728 - Gehrmann; Mathias ; et al.	2017-03-23
Method For Breast Cancer Recurrence Prediction Under Endocrine Treatment App 20170067118 - Dartmann; Mareike ; et al.	2017-03-09
Method For Predicting The Response And Survival From Chemotherapy In Patients With Breast Cancer App 20160348183 - BRASE; Jan Christoph ; et al.	2016-12-01
Method For Predicting The Benefit From Inclusion Of Taxane In A Chemotherapy Regimen In Patients With Breast Cancer App 20150376714 - Brase; Jan Christoph ; et al.	2015-12-31
Method For Predicting The Response To Chemotherapy In A Patient Suffering From Or At Risk Of Developing Recurrentbreast Cancer App 20140228241 - Gehrmann; Mathias ; et al.	2014-08-14
Method For Breast Cancer Recurrence Prediction Under Endocrine Treatment App 20130065786 - Dartmann; Mareike ; et al.	2013-03-14
Algorithms For Outcome Prediction In Patients With Node-positive Chemotherapy-treated Breast Cancer App 20110166838 - Gehrmann; Mathias ; et al.	2011-07-07
Method For Predicting Therapy Responsiveness In Basal Like Tumors App 20110118129 - Wirtz; Ralph Markus ; et al.	2011-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.